Nerve Transfer After Spinal Cord Injuries
Primary Purpose
Spinal Cord Injury
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Nerve Transfer
Sponsored by
About this trial
This is an interventional treatment trial for Spinal Cord Injury focused on measuring Spinal cord injury, nerve transfer, tetraplegia, quadriplegia
Eligibility Criteria
Inclusion Criteria:
- 18-65 years of age
- Informed Consent Document (ICD) signed by patient
- Cervical spinal cord injury resulting in arm & hand functional impairment, with at least preserved elbow function
- International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0 - 4
- Patients with a stable American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury
- Appropriate candidate for nerve transfer study
- Willing and able to comply with the study protocol
- < 48 months from injury
Exclusion Criteria:
- Active infection at the operative site or systemic infection
- Any return or ongoing clinical recovery of distal motor function within 6 months after injury
- Physically or mentally compromised
- Currently undergoing long-term steroid therapy
- Significant joint contractures and/or limitations in passive range of motion in the arm or hand
- Active malignancy
- Systemic disease that would affect the patient's welfare or the research study
- Pregnant
- Immunologically suppressed or immunocompromised
- Significant pain or hypersensitivity
- Previous or current injury preventing use of tendon transfers to restore upper extremity function
- Affective disorder of a degree that would make outcome assessment and study participation difficult
- History of brachial plexus injury or systemic neuropathic process
Sites / Locations
- Washington University
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Nerve Transfer
Arm Description
Surgical - Nerve transfers for patients with stable cervical spinal cord injuries
Outcomes
Primary Outcome Measures
Change in upper motor strength
Patients motor strength will be assessed over 48 months of clinical follow-up with conventional manual motor testing
Secondary Outcome Measures
Change in Disabilities of Arm, Shoulder, and Hand (DASH) scores
The change in DASH scores will be followed over time and assessed pre-operatively, 6,12, 18, 24, 36 and 48 months post-operatively.
Change in Short Form 36 (SF-36) scores
The change in SF-36 scores will be followed over time and assessed pre-operatively, 6, 12, 18, 24. 36 and 48 months post-operatively.
Change in Michigan Hand Questionnaire (MHQ)
The change in MHQ will be followed over time and assessed pre-operatively, 6, 12, 18, 24, 36 and 48 months post-operatively.
Full Information
NCT ID
NCT01714349
First Posted
October 22, 2012
Last Updated
March 21, 2023
Sponsor
Washington University School of Medicine
Collaborators
United States Department of Defense
1. Study Identification
Unique Protocol Identification Number
NCT01714349
Brief Title
Nerve Transfer After Spinal Cord Injuries
Official Title
Restoring Hand Function Using Nerve Transfers in Persons With Spinal Cord Injury
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
March 20, 2023 (Actual)
Study Completion Date
March 20, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine
Collaborators
United States Department of Defense
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Nerve Transfer surgery can provide improved hand function following cervical spinal cord injuries
Detailed Description
Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of life and long-term functional independence will provide a significant public health impact.
Specific Aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete cervical spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and optimal timing the the surgery.
Hypothesis: Peripheral nerve transfers in patients with spinal cord injuries will improve hand function and provide improvement in patient quality of life and functional independence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injury
Keywords
Spinal cord injury, nerve transfer, tetraplegia, quadriplegia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Nerve Transfer
Arm Type
Experimental
Arm Description
Surgical - Nerve transfers for patients with stable cervical spinal cord injuries
Intervention Type
Procedure
Intervention Name(s)
Nerve Transfer
Intervention Description
A nerve transfer procedure will be individualized to each patient's functional deficit.
Primary Outcome Measure Information:
Title
Change in upper motor strength
Description
Patients motor strength will be assessed over 48 months of clinical follow-up with conventional manual motor testing
Time Frame
48 months
Secondary Outcome Measure Information:
Title
Change in Disabilities of Arm, Shoulder, and Hand (DASH) scores
Description
The change in DASH scores will be followed over time and assessed pre-operatively, 6,12, 18, 24, 36 and 48 months post-operatively.
Time Frame
48 months
Title
Change in Short Form 36 (SF-36) scores
Description
The change in SF-36 scores will be followed over time and assessed pre-operatively, 6, 12, 18, 24. 36 and 48 months post-operatively.
Time Frame
48 months
Title
Change in Michigan Hand Questionnaire (MHQ)
Description
The change in MHQ will be followed over time and assessed pre-operatively, 6, 12, 18, 24, 36 and 48 months post-operatively.
Time Frame
48 months
Other Pre-specified Outcome Measures:
Title
Rates of Intraoperative and Post-operative complications
Description
The number of complications within and after the operation.
Time Frame
48 months
Title
Effect of timing on surgical intervention
Description
Assess the effect of timing on primary and secondary outcome measures, early (<12 months) vs. (>12 months)
Time Frame
48 months
Title
Rate of reoperation
Description
The rate at which a patient needs to be operated on again.
Time Frame
48 months
Title
Hand Function, measured by the Sollerman Hand Function Test
Description
The Sollerman Hand Function Test is performed as part of an overall evaluation and assessment by study team Occupational Therapist pre-operatively, post-operatively, and at 6 months, 12 months, 18 months, and 24 months. 36 months and 48 months
Time Frame
48 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18-65 years of age
Informed Consent Document (ICD) signed by patient
Cervical spinal cord injury resulting in arm & hand functional impairment, with at least preserved elbow function
International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0 - 4
Patients with a stable American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury
Appropriate candidate for nerve transfer study
Willing and able to comply with the study protocol
< 48 months from injury
Exclusion Criteria:
Active infection at the operative site or systemic infection
Any return or ongoing clinical recovery of distal motor function within 6 months after injury
Physically or mentally compromised
Currently undergoing long-term steroid therapy
Significant joint contractures and/or limitations in passive range of motion in the arm or hand
Active malignancy
Systemic disease that would affect the patient's welfare or the research study
Pregnant
Immunologically suppressed or immunocompromised
Significant pain or hypersensitivity
Previous or current injury preventing use of tendon transfers to restore upper extremity function
Affective disorder of a degree that would make outcome assessment and study participation difficult
History of brachial plexus injury or systemic neuropathic process
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wilson Z Ray, MD
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington University
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.neurosurgery.wustl.edu
Description
Washington University Neurosurgery Home Page
Learn more about this trial
Nerve Transfer After Spinal Cord Injuries
We'll reach out to this number within 24 hrs